Inovaker Lab's Hand+ sanitizer labeled 75% ethanol contained 0% ethanol and was refused entry to the U.S.
What happened
FDA tested a batch of Hand+ Sanitizer Ethyl Alcohol Antiseptic 75% Topical Solution that was detained and refused admission at the U.S. border. The product was labeled as and declared to be manufactured at Inovaker Lab's Monterrey facility, but laboratory testing found no ethanol (0% v/v) although the label stated 75% v/v. FDA also cited the product as an unapproved new drug and misbranded, and said the firm had not recalled it after a September 23, 2020 teleconference.
What FDA found
The product was labeled to contain 75% ethanol but testing found 0% ethanol, so its strength and quality fell below what it claimed.
FD&C Act section 501(c), 21 U.S.C. 351(c)The lack of active ingredient showed that quality assurance at the facility was not working under CGMP requirements.
FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)The hand sanitizer was an unapproved new drug marketed without FDA approval.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The label falsely said the product contained 75% ethanol, making the labeling false or misleading.
FD&C Act section 502(a), 21 U.S.C. 352(a)The nonprescription drug did not meet the requirements for marketing under section 505G and had no approved application.
FD&C Act section 502(ee), 21 U.S.C. 352(ee)
What FDA wants
FDA asks Inovaker to respond in writing within 15 working days with a detailed investigation into the 0% ethanol result, lists of raw materials and U.S.-shipped batches, batch records, and test methods, specifications, and results; FDA also recommends a qualified CGMP consultant.
Who should pay attention
- U.S. distributors and retailers that received Hand+ sanitizer
- health care facilities and consumers using ethanol-based hand sanitizers
- importers and brands sourcing hand sanitizer from contract manufacturers
This is a summary. Read the original letter on fda.gov.